SKLB-D18
SKLB-D18 is a potent and selective inhibitor of ERK1/2 and ERK5, with IC50s of 38.69, 40.12 and 59.72 nM, respectively. SKLB-D18 is also an autophagy agonist, plays a role in mTOR/p70S6K and NCOA4-mediated ferroptosis, which may mitigate multidrug resistance. SKLB-D18 exhibits significantly superior efficacy in vitro and in vivo against triple-negative breast cancer (TNBC) [1].
Product Specifications
UNSPSC
12352005
Target
Autophagy; ERK
Related Pathways
Autophagy; MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
CN(C)CC1=CC=CC(NC2=NC(C3=CSC(C(NN4CCOCC4)=O)=C3)=C(Cl)C=N2)=C1
Molecular Formula
C22H25ClN6O2S
Molecular Weight
472.99
References & Citations
[1]Xiao H, et, al. A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy. Signal Transduct Target Ther. 2025 Feb 20;10 (1) :70.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC429002 20 µg
FKBP51 (FKBP5) (NM_001145775) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC741227-100 1x 100 µL
Thyroglobulin (TGB04 + TGB05), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![FITC Anti-Human HLA-DQ Antibody[1a3]](https://cdn.genprice.uk/products/763/68dd14af061270361e7d38ed/imageurl08/an00421c.webp)